Eventide Asset Management - Q4 2022 holdings

$5.07 Billion is the total value of Eventide Asset Management's 143 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 29.7% .

 Value Shares↓ Weighting
MTD BuyMETTLER TOLEDO INTERNATIONAL$187,360,674
+41.0%
129,621
+5.8%
3.70%
+41.4%
DOCS BuyDOXIMITY INCcl a$131,820,358
+27.9%
3,927,901
+15.1%
2.60%
+28.2%
TT BuyTRANE TECHNOLOGIES PLC$129,612,854
+16.1%
771,092
+0.0%
2.56%
+16.4%
ODFL BuyOLD DOMINION FREIGHT LINE IN$126,478,476
+14.1%
445,692
+0.0%
2.49%
+14.4%
ARGX BuyARGENX SEsponsored adr$124,584,686
+10.5%
328,867
+3.0%
2.46%
+10.7%
ROP BuyROPER TECHNOLOGIES INC$120,125,774
+24.7%
278,011
+3.8%
2.37%
+25.0%
RXDX SellPROMETHEUS BIOSCIENCES INC$113,623,180
-27.9%
1,032,938
-61.3%
2.24%
-27.7%
HZNP BuyHORIZON THERAPEUTICS PUB L$113,367,560
+88.6%
996,200
+2.6%
2.24%
+88.9%
WCN BuyWASTE CONNECTIONS INC$106,933,898
-1.7%
806,683
+0.2%
2.11%
-1.5%
IDXX BuyIDEXX LABS INC$105,151,282
+25.3%
257,749
+0.1%
2.07%
+25.6%
NEP  NEXTERA ENERGY PARTNERS LP$102,201,173
-3.1%
1,458,1420.0%2.02%
-2.8%
KRTX  KARUNA THERAPEUTICS INC$102,121,050
-12.6%
519,7000.0%2.01%
-12.4%
PANW BuyPALO ALTO NETWORKS INC$98,735,713
-13.8%
707,580
+1.2%
1.95%
-13.6%
FLYW BuyFLYWIRE CORPORATION$98,498,797
+138.3%
4,025,288
+123.6%
1.94%
+138.9%
ZI BuyZOOMINFO TECHNOLOGIES INC$96,567,527
-8.5%
3,207,158
+26.6%
1.90%
-8.3%
ASND SellASCENDIS PHARMA A/Ssponsored adr$95,592,250
-22.8%
782,709
-34.7%
1.88%
-22.6%
DLO BuyDLOCAL LTD$93,356,568
+15.4%
5,995,926
+52.0%
1.84%
+15.6%
EXAS  EXACT SCIENCES CORP$92,453,241
+52.4%
1,867,3650.0%1.82%
+52.7%
LOW BuyLOWES COS INC$89,435,449
+8.7%
448,883
+2.5%
1.76%
+9.0%
POOL  POOL CORP$74,705,743
-5.0%
247,1000.0%1.47%
-4.8%
FIVN SellFIVE9 INC$70,767,869
-30.3%
1,042,851
-23.0%
1.40%
-30.2%
DV BuyDOUBLEVERIFY HLDGS INC$70,686,934
+39.9%
3,218,895
+74.3%
1.39%
+40.2%
XMTR BuyXOMETRY INC$67,787,167
-26.1%
2,103,232
+30.2%
1.34%
-25.9%
APTV BuyAPTIV PLC$67,088,896
+19.1%
720,379
+0.0%
1.32%
+19.4%
TTD SellTHE TRADE DESK INC$65,674,022
-40.1%
1,464,957
-20.1%
1.30%
-39.9%
IMVT SellIMMUNOVANT INC$65,563,530
+118.7%
3,693,720
-31.2%
1.29%
+119.2%
CLDX SellCELLDEX THERAPEUTICS INC NEW$65,208,139
+29.5%
1,463,050
-18.3%
1.29%
+29.8%
CRWD SellCROWDSTRIKE HLDGS INCcl a$64,038,010
-36.2%
608,206
-0.1%
1.26%
-36.0%
DHI SellD R HORTON INC$61,329,479
+25.3%
688,013
-5.3%
1.21%
+25.5%
COLL  COLLEGIUM PHARMACEUTICAL INC$61,006,558
+44.8%
2,629,5930.0%1.20%
+45.1%
LNG SellCHENIERE ENERGY INC$59,406,054
-11.6%
396,146
-2.2%
1.17%
-11.4%
GLBE BuyGLOBAL E ONLINE LTD$57,630,203
-14.0%
2,792,161
+11.5%
1.14%
-13.8%
EVH BuyEVOLENT HEALTH INCcl a$53,429,360
+586.2%
1,902,755
+778.1%
1.05%
+588.9%
HUBS SellHUBSPOT INC$51,560,842
-11.2%
178,331
-17.0%
1.02%
-10.9%
SPT SellSPROUT SOCIAL INC$48,981,704
-18.5%
867,547
-12.5%
0.97%
-18.3%
CCI SellCROWN CASTLE INC$48,467,699
-10.3%
357,326
-4.4%
0.96%
-10.1%
LRCX BuyLAM RESEARCH CORP$48,408,893
+16.4%
115,177
+1.3%
0.96%
+16.6%
ENTG BuyENTEGRIS INC$46,379,607
-14.0%
707,114
+8.9%
0.92%
-13.7%
GH  GUARDANT HEALTH INC$45,723,200
-49.5%
1,681,0000.0%0.90%
-49.3%
ENPH BuyENPHASE ENERGY INC$45,064,662
-0.4%
170,081
+4.3%
0.89%
-0.1%
ZNTL BuyZENTALIS PHARMACEUTICALS INC$43,432,212
+7.7%
2,156,515
+15.9%
0.86%
+7.9%
MPWR SellMONOLITHIC PWR SYS INC$41,601,156
-3.5%
117,647
-0.8%
0.82%
-3.3%
LSCC SellLATTICE SEMICONDUCTOR CORP$40,234,034
+28.0%
620,130
-2.9%
0.79%
+28.3%
MIRM BuyMIRUM PHARMACEUTICALS INC$40,111,500
+49.7%
2,057,000
+61.3%
0.79%
+50.1%
COUR BuyCOURSERA INC$39,857,388
+39.3%
3,369,179
+26.9%
0.79%
+39.6%
ASML BuyASML HOLDING N V$37,758,426
+31.6%
69,104
+0.0%
0.74%
+31.9%
SHLS BuySHOALS TECHNOLOGIES GROUP INcl a$37,518,925
+180.4%
1,520,832
+145.0%
0.74%
+181.4%
TREX SellTREX CO INC$37,335,060
-14.2%
882,000
-10.9%
0.74%
-14.0%
DDOG SellDATADOG INC$37,185,561
-17.5%
505,926
-0.3%
0.73%
-17.4%
CWEN BuyCLEARWAY ENERGY INCcl c$36,909,125
+1.5%
1,158,115
+1.5%
0.73%
+1.8%
NVT SellNVENT ELECTRIC PLC$32,509,304
+17.8%
845,056
-3.2%
0.64%
+18.0%
BEP  BROOKFIELD RENEWABLE PARTNERpartnership unit$31,320,240
-19.0%
1,236,0000.0%0.62%
-18.8%
SGEN NewSEAGEN INC$31,169,458242,545
+100.0%
0.62%
VRSK BuyVERISK ANALYTICS INC$30,378,289
+12.9%
172,193
+9.1%
0.60%
+13.2%
COGT SellCOGENT BIOSCIENCES INC$29,937,834
-29.9%
2,589,778
-9.5%
0.59%
-29.8%
RPRX NewROYALTY PHARMA PLC$29,577,677748,423
+100.0%
0.58%
VECT BuyVECTIVBIO HLDG AG$29,322,595
+108.9%
3,405,644
+45.6%
0.58%
+109.4%
BILL BuyBILL COM HLDGS INC$28,908,178
+1646.7%
265,310
+2022.5%
0.57%
+1627.3%
NDAQ BuyNASDAQ INC$28,931,617
+16.7%
471,583
+7.9%
0.57%
+16.8%
CDW BuyCDW CORP$27,709,723
+24.4%
155,167
+8.7%
0.55%
+24.7%
INSP BuyINSPIRE MED SYS INC$27,258,454
+82.8%
108,220
+28.8%
0.54%
+83.6%
PRTA BuyPROTHENA CORP PLC$26,433,603
+89.6%
438,732
+90.8%
0.52%
+90.1%
STE BuySTERIS PLC$25,754,097
+11.1%
139,445
+0.1%
0.51%
+11.4%
CYTK NewCYTOKINETICS INC$25,475,920556,000
+100.0%
0.50%
XENE  XENON PHARMACEUTICALS INC$25,282,516
+9.2%
641,2000.0%0.50%
+9.7%
BCYC  BICYCLE THERAPEUTICS PLCsponsored ads$25,272,480
+27.3%
853,8000.0%0.50%
+27.4%
WMB BuyWILLIAMS COS INC$25,100,693
+16.4%
762,939
+1.3%
0.50%
+16.7%
HASI  HANNON ARMSTRONG SUST INFR C$23,840,803
-3.2%
822,6640.0%0.47%
-2.9%
BMRN NewBIOMARIN PHARMACEUTICAL INC$23,802,700230,000
+100.0%
0.47%
NewAURA BIOSCIENCES INC$23,639,3642,251,368
+100.0%
0.47%
PRVA BuyPRIVIA HEALTH GROUP INC$22,710,000
+60.3%
1,000,000
+140.4%
0.45%
+60.6%
IRTC BuyIRHYTHM TECHNOLOGIES INC$22,399,775
+20.1%
239,135
+60.7%
0.44%
+20.4%
NARI BuyINARI MED INC$22,227,631
+15.0%
349,711
+31.5%
0.44%
+15.3%
BEPC  BROOKFIELD RENEWABLE CORPcl a sub vtg$21,344,023
-15.7%
775,0190.0%0.42%
-15.5%
SNPS BuySYNOPSYS INC$20,553,017
+29.0%
64,371
+23.4%
0.40%
+29.0%
RGEN  REPLIGEN CORP$20,147,890
-9.5%
119,0000.0%0.40%
-9.4%
ISRG  INTUITIVE SURGICAL INC$19,901,250
+41.6%
75,0000.0%0.39%
+41.5%
BPMC  BLUEPRINT MEDICINES CORP$19,210,685
-33.5%
438,5000.0%0.38%
-33.3%
KLAC SellKLA CORP$19,063,391
+17.0%
50,562
-6.1%
0.38%
+17.1%
ANNX  ANNEXON INC$18,749,046
-16.3%
3,626,5080.0%0.37%
-16.1%
ESI  ELEMENT SOLUTIONS INC$17,662,490
+11.8%
971,0000.0%0.35%
+11.9%
APLS  APELLIS PHARMACEUTICALS INC$17,548,047
-24.3%
339,3550.0%0.35%
-24.1%
AESC  AES CORPunit 02/15/2024$17,464,112
+15.4%
171,2000.0%0.34%
+15.4%
VCYT  VERACYTE INC$17,370,360
+43.0%
732,0000.0%0.34%
+43.5%
AJG BuyGALLAGHER ARTHUR J & CO$17,361,140
+198.8%
92,082
+171.4%
0.34%
+200.0%
NOVT  NOVANTA INC$17,106,033
+17.5%
125,9000.0%0.34%
+17.8%
MASS Buy908 DEVICES INC$16,997,667
-39.8%
2,230,665
+30.0%
0.34%
-39.6%
WEC SellWEC ENERGY GROUP INC$16,894,802
-7.1%
180,192
-11.4%
0.33%
-7.0%
RARE BuyULTRAGENYX PHARMACEUTICAL IN$16,632,470
+31.3%
359,000
+17.4%
0.33%
+31.7%
NBIX SellNEUROCRINE BIOSCIENCES INC$16,124,400
-35.4%
135,000
-42.6%
0.32%
-35.2%
FRC BuyFIRST REP BK SAN FRANCISCO C$16,134,701
-6.4%
132,371
+0.3%
0.32%
-6.2%
IEX BuyIDEX CORP$15,790,618
+35.3%
69,157
+18.4%
0.31%
+35.2%
PNR  PENTAIR PLC$15,760,992
+10.7%
350,4000.0%0.31%
+11.1%
INSM NewINSMED INC$13,954,292698,413
+100.0%
0.28%
BRKR NewBRUKER CORP$13,807,110202,006
+100.0%
0.27%
SYY  SYSCO CORP$13,539,295
+8.1%
177,1000.0%0.27%
+8.5%
 ROIVANT SCIENCES LTD$13,505,497
+153.4%
1,690,3000.0%0.27%
+153.3%
SHW BuySHERWIN WILLIAMS CO$12,684,577
+231.4%
53,447
+185.9%
0.25%
+233.3%
NewMARINUS PHARMACEUTICALS INC$12,537,0003,150,000
+100.0%
0.25%
CMS SellCMS ENERGY CORP$12,381,015
-12.2%
195,500
-19.3%
0.24%
-11.9%
EHC  ENCOMPASS HEALTH CORP$11,632,746
+32.2%
194,4950.0%0.23%
+32.4%
NTLA  INTELLIA THERAPEUTICS INC$11,129,910
-37.7%
319,0000.0%0.22%
-37.6%
BEAM  BEAM THERAPEUTICS INC$10,443,348
-17.9%
267,0250.0%0.21%
-17.6%
TRGP BuyTARGA RES CORP$10,257,734
+369.7%
139,561
+285.5%
0.20%
+369.8%
BAX  BAXTER INTL INC$10,122,642
-5.4%
198,6000.0%0.20%
-4.8%
ALXO  ALX ONCOLOGY HLDGS INC$10,165,540
+17.8%
902,0000.0%0.20%
+17.6%
ICPT  INTERCEPT PHARMACEUTICALS IN$9,896,000
-11.3%
800,0000.0%0.20%
-11.4%
KDNY NewCHINOOK THERAPEUTICS INC$9,662,848368,811
+100.0%
0.19%
 GXO LOGISTICS INCORPORATED$9,391,800
+21.8%
220,0000.0%0.18%
+21.7%
MRTX  MIRATI THERAPEUTICS INC$9,225,116
-35.1%
203,6000.0%0.18%
-35.0%
RCKT NewROCKET PHARMACEUTICALS INC$9,210,699470,654
+100.0%
0.18%
NewAMYLYX PHARMACEUTICALS INC$9,237,500250,000
+100.0%
0.18%
APTVPRA NewAPTIV PLC5.5% cnv pfd a$8,448,07078,500
+100.0%
0.17%
PRAX  PRAXIS PRECISION MEDICINES I$8,372,988
+4.8%
3,518,0620.0%0.16%
+5.1%
SWAV  SHOCKWAVE MED INC$8,162,717
-26.1%
39,7000.0%0.16%
-25.8%
ELS  EQUITY LIFESTYLE PPTYS INC$7,970,671
+2.8%
123,3850.0%0.16%
+2.6%
EGP BuyEASTGROUP PPTYS INC$7,522,632
+2.6%
50,808
+0.0%
0.15%
+2.8%
WD  WALKER & DUNLOP INC$7,419,107
-6.3%
94,5350.0%0.15%
-6.4%
ADCT  ADC THERAPEUTICS SA$7,219,043
-20.3%
1,879,9590.0%0.14%
-20.2%
EQT BuyEQT CORP$6,978,825
+109.0%
206,291
+151.8%
0.14%
+109.1%
SNV BuySYNOVUS FINL CORP$6,910,251
+32.1%
184,028
+31.9%
0.14%
+32.0%
PLD BuyPROLOGIS INC.$6,816,332
+544.9%
60,466
+481.4%
0.13%
+538.1%
DVN NewDEVON ENERGY CORP NEW$6,621,982107,657
+100.0%
0.13%
RCUS NewARCUS BIOSCIENCES INC$4,963,200240,000
+100.0%
0.10%
CMPX SellCOMPASS THERAPEUTICS INC$4,703,508
+87.5%
935,091
-15.0%
0.09%
+89.8%
ARE  ALEXANDRIA REAL ESTATE EQ IN$4,710,239
+3.9%
32,3350.0%0.09%
+4.5%
IONS  IONIS PHARMACEUTICALS INC$4,154,700
-14.6%
110,0000.0%0.08%
-14.6%
XPO  XPO INC$3,828,350
-25.2%
115,0000.0%0.08%
-25.7%
NewNEXTERA ENERGY INCunit 09/01/2025 added$3,764,25075,000
+100.0%
0.07%
FRLN SellFREELINE THERAPEUTICS HLDGSsponsored ads$2,917,370
-28.7%
5,920,765
-0.5%
0.06%
-27.5%
BuyARTERIS INC$2,640,944
+0.1%
614,173
+55.1%
0.05%0.0%
NewRXO INC$1,978,000115,000
+100.0%
0.04%
ZTS SellZOETIS INCcl a$1,987,804
-56.4%
13,564
-55.9%
0.04%
-56.7%
KALV  KALVISTA PHARMACEUTICALS INC$1,867,112
-53.4%
276,2000.0%0.04%
-53.2%
TALS  TALARIS THERAPEUTICS INC$1,592,314
-61.2%
1,561,0920.0%0.03%
-61.7%
WDAY NewWORKDAY INCcl a$309,0591,847
+100.0%
0.01%
NEE NewNEXTERA ENERGY INC$184,5052,207
+100.0%
0.00%
EW NewEDWARDS LIFESCIENCES CORP$194,5082,607
+100.0%
0.00%
NOW NewSERVICENOW INC$184,817476
+100.0%
0.00%
ORLY NewOREILLY AUTOMOTIVE INC$158,678188
+100.0%
0.00%
TSM SellTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$115,013
-99.6%
1,544
-99.6%
0.00%
-99.6%
NVDA NewNVIDIA CORPORATION$82,131562
+100.0%
0.00%
NXPI NewNXP SEMICONDUCTORS N V$58,313369
+100.0%
0.00%
WMS ExitADVANCED DRAIN SYS INC DEL$0-8,752
-100.0%
-0.02%
ExitGUARDANT HEALTH INCnote 11/1$0-2,900,000
-100.0%
-0.04%
EPIX ExitESSA PHARMA INC$0-1,561,251
-100.0%
-0.06%
PHVS ExitPHARVARIS N V$0-450,251
-100.0%
-0.07%
BCAB ExitBIOATLA INC$0-795,000
-100.0%
-0.12%
OPCH ExitOPTION CARE HEALTH INC$0-221,500
-100.0%
-0.14%
APTVPRA ExitAPTIV PLC5.5% cnv pfd a$0-78,500
-100.0%
-0.15%
YETI ExitYETI HLDGS INC$0-369,000
-100.0%
-0.21%
ARVN ExitARVINAS INC$0-281,500
-100.0%
-0.25%
STRO ExitSUTRO BIOPHARMA INC$0-2,708,975
-100.0%
-0.30%
REXR ExitREXFORD INDL RLTY INC$0-460,209
-100.0%
-0.47%
ZYME ExitZYMEWORKS INC$0-5,380,200
-100.0%
-0.65%
A ExitAGILENT TECHNOLOGIES INC$0-358,200
-100.0%
-0.86%
GNRC ExitGENERAC HLDGS INC$0-269,700
-100.0%
-0.94%
MDB ExitMONGODB INCcl a$0-289,160
-100.0%
-1.13%
KNBE ExitKNOWBE4 INCcl a$0-3,267,317
-100.0%
-1.34%
ExitBIOHAVEN LTD$0-495,432
-100.0%
-1.47%
CTAS ExitCINTAS CORP$0-277,421
-100.0%
-2.12%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-13
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings